HPHWD

Après sept ans de bras de fer, la Cour suprême indienne a rejeté la demande de brevet déposée par Novartis pour son produit vedette, le Glivec. Depuis 2006, le groupe suisse souhaitait faire breveter en Inde la nouvelle version de cet anticancéreux, comme il l’a fait dans près de quarante pays, dont les Etats-Unis, la Russie et la Chine.

Their 2012 Annual Report is a very disturbing report from WHO, for at least two reasons:

1. Their program is gradually falling apart, and they offer no way to refocus, no strategy for dealing with the loss in funding, nor the brick wall of drug and biocide resistance which is just down the road. There is a label for people who keep doing the same thing, but expect different results. Do you remember what it is?

2. Because the entire top management of WHO consists of physicians, they have no idea of the opportunities they are missing for additional funding and for additional methods to add to their chemically-oriented strategy…

Murray heads the Institute for Health Metrics and Evaluation (IHME), a branch of the University of Washington (UW) that contends it has created the most detailed and authoritative report ever on the state of the world’s health. The so-called Global Burden of Disease (GBD) 2010 study will appear on 15 December in the largest issue of The Lancet ever published, and Murray hopes it will have a major impact on how policymakers, donors, and researchers allocate resources to help people lead healthier, longer lives.

This commentary argues that there are three major crises confronting global health: ongoing financial crises; deepening ecological crises; and rapidly escalating income and wealth inequalities within and between nations. Global rhetorical responses to these crises frequently invoke policy sentiments similar to those advised by the 2008 WHO Commission on Social Determinants of Health (CSDH). However, actual policy decisions run counter to the evidence reviewed by the Commission, and its final report recommendations. Failure to re-regulate financial capitalism, introduce regulatory standards for transnational companies, or subordinate trade and investment liberalization treaties to development goals and human rights treaties will exacerbate global health inequities into the future. More positively, there is increasing support for systems of global taxation. The challenge for global health, however, will remain the willingness of states to make domestic and foreign policy choices that strengthen income redistribution, economic regulation, and citizen rights.

1 confirmed case: “pandemic”; all domestic news except high-profile sex scandals is preempted. Anderson Cooper announces a special investigation.

Based within the Department of Epidemiology and Public Health, the Global Health Equity Group (GHEG) is concerned with research, training and knowledge translation in matters relating to the unequal distribution of power, income, goods, and services (structural determinants), the consequent unfairness in the immediate circumstances of people’s lives - their access to health care, schools, and education, their conditions of work and leisure, their homes, communities, towns, or cities (daily living conditions), and the effects on health inequities - within and between countries.